Random-start gonadotropin-releasing hormone (GnRH) antagonist–treated cycles with GnRH agonist trigger for fertility preservation
Authors:
- 1 July 2011
- journal article
- editorial
- Published by Elsevier in Fertility and Sterility
- Vol. 96 (1) , e51-e54
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cyclesFertility and Sterility, 2011
- Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles2011
- Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literatureJournal of Assisted Reproduction and Genetics, 2010
- 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled studyFertility and Sterility, 2010
- Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor programFertility and Sterility, 2010
- Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phaseFertility and Sterility, 2009
- Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trialGynecological Endocrinology, 2009
- Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation ratesFertility and Sterility, 2006
- Serum inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trialHuman Reproduction, 2006
- Characterization of Ovarian Follicular Wave Dynamics in Women1Biology of Reproduction, 2003